A functional variant in the immune signalling receptor NKG2D alters skin cancer risk

Br J Dermatol. 2022 May;186(5):898-899. doi: 10.1111/bjd.20943. Epub 2022 Mar 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Ligands
  • NK Cell Lectin-Like Receptor Subfamily K*
  • Signal Transduction
  • Skin
  • Skin Neoplasms*

Substances

  • Ligands
  • NK Cell Lectin-Like Receptor Subfamily K